Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
about
Theranostic impact of NG2/CSPG4 proteoglycan in cancerIdentification of tumor associated single-chain Fv by panning and screening antibody phage library using tumor cells.Human TGFalpha-derived peptide TGFalphaL3 fused with superantigen for immunotherapy of EGFR-expressing tumours.Superantigens increase the survival of mice bearing T cell lymphomas by inducing apoptosis of neoplastic cells.CSPG4: a prototype oncoantigen for translational immunotherapy studies.Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy.Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F(ab')(2) fragment and staphylococcal enterotoxin A.Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.Potent antitumor effect elicited by superantigen-linked tumor cells transduced with heat shock protein 70 gene.Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3.RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.Recent Innovations and Analytical Applications of Phage Display Libraries
P2860
Q28085331-A5484C03-D4DC-4256-9392-D0EE3809106AQ30842459-69961C1C-5B8E-49A1-A51D-4A43D5AED04BQ33777481-0DD11036-A309-416F-9115-DF49BFC416D2Q33784728-FB23A914-2242-4434-A5B2-CEC140E9FF3EQ33862585-F794C933-CC2F-49CE-878C-251A6B7706CEQ35419158-E24C02DF-203B-4B1C-B577-4FFA908BDF23Q36491963-29206AB1-66E2-4BAF-A444-217A89180EB4Q38823747-6F5CF7BB-C38F-4084-A3FA-E6D4266965D5Q40589727-0B16C20A-E206-42A4-85B2-A3DBE0E90378Q40741125-5D717F02-42BE-4756-B470-6DECD0A74B97Q41450925-21ECFD24-0372-4314-8C58-92142C4D641CQ43501855-1EDE1FA1-7F54-461B-AB80-092294A96EC3Q58136668-403349EE-F15B-4316-A1A6-93366B3B7575
P2860
Phage-selected primate antibodies fused to superantigens for immunotherapy of malignant melanoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Phage-selected primate antibod ...... therapy of malignant melanoma.
@ast
Phage-selected primate antibod ...... therapy of malignant melanoma.
@en
type
label
Phage-selected primate antibod ...... therapy of malignant melanoma.
@ast
Phage-selected primate antibod ...... therapy of malignant melanoma.
@en
prefLabel
Phage-selected primate antibod ...... therapy of malignant melanoma.
@ast
Phage-selected primate antibod ...... therapy of malignant melanoma.
@en
P2093
P356
P1476
Phage-selected primate antibod ...... therapy of malignant melanoma.
@en
P2093
Abrahmsén LB
Karlström PJ
Ohlsson LG
Tordsson JM
P2888
P304
P356
10.1007/S002620050018
P577
2000-03-01T00:00:00Z
P6179
1028652016